Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Mendelian Genomics, |
RCV001198921 | SCV001369916 | uncertain significance | Rubinstein-Taybi syndrome due to CREBBP mutations | 2020-02-27 | criteria provided, single submitter | clinical testing | This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PM2. |
Fulgent Genetics, |
RCV002480650 | SCV002793303 | uncertain significance | Rubinstein-Taybi syndrome due to CREBBP mutations; Menke-Hennekam syndrome 1 | 2021-11-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002560261 | SCV003452368 | benign | Rubinstein-Taybi syndrome | 2024-05-23 | criteria provided, single submitter | clinical testing |